Clinical evaluation of leech therapy in chillbain (Frostbite)

Clinical Evaluation of Leech Therapy (Irsal-e-Alaq) in Frostbite Across High-Risk Age Groups: Establishing Documented Evidence - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/07/113291

Enrollment

100

Registered

2026-07-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T338- Superficial frostbite of ankle, foot, and toe(s)

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed frostbite 2. Lesions on fingers, toes, heels, or ears 3. Willingness to participate and provide written informed consent (parental consent for minors)

Exclusion criteria

Exclusion criteria: 1. Active infection, ulceration, or gangrene at the lesion site 2. Bleeding disorders or current anticoagulant therapy 3. Severe anemia (Hb less than 9 g/dL) 4. Pregnancy or lactation 5. Known hypersensitivity to leech saliva

Design outcomes

Primary

Measure	Time frame
Change in lesion severity score (pain, erythema, swelling, itching)Timepoint: Day 0, Day 15, Day 30, Day 45 and Day 60	—

Secondary

Measure	Time frame
1. Healing time 2. Patient Global Assessment 3. Lesion PhotographyTimepoint: Day 0 (Baseline) and Day 60	—

Countries

India

Contacts

Public ContactARSHEED IQBAL

Reginoal Research Institute of Unani Medicine

drarsheediqbal@gmail.com07006019911

Outcome results